{"_id": "19740399|None", "id": "19740399", "infons": {}, "passages": [{"infons": {"journal": "Br J Clin Pharmacol; 2009 Sep; 68(3) 413-21. doi:10.1111/j.1365-2125.2009.03461.x", "year": "2009", "article-id_pmc": "PMC2766481", "type": "title", "authors": "Hawwa AF, McKiernan PJ, Shields M, Millership JS, Collier PS, McElnay JC", "section": "Title"}, "offset": 0, "text": "Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant.", "sentences": [], "annotations": [{"id": "4", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 13, "length": 5}]}, {"id": "5", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 51, "length": 10}]}, {"id": "6", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephrotoxicity", "locations": [{"offset": 62, "length": 14}]}, {"id": "7", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 104, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 136, "text": "AIMS: The aim of this study was to investigate the influence of genetic polymorphisms in ABCB1 on the incidence of nephrotoxicity and tacrolimus dosage-requirements in paediatric patients following liver transplantation. METHODS: Fifty-one paediatric liver transplant recipients receiving tacrolimus were genotyped for ABCB1 C1236&gt;T, G2677&gt;T and C3435&gt;T polymorphisms. Dose-adjusted tacrolimus trough concentrations and estimated glomerular filtration rates (EGFR) indicative of renal toxicity were determined and correlated with the corresponding genotypes. RESULTS: The present study revealed a higher incidence of the ABCB1 variant-alleles examined among patients with renal dysfunction (&gt; or =30% reduction in EGFR) at 6 months post-transplantation (1236T allele: 63.3% vs 37.5% in controls, P= 0.019; 2677T allele: 63.3% vs. 35.9%, p = 0.012; 3435T allele: 60% vs. 39.1%, P= 0.057). Carriers of the G2677-&gt;T variant allele also had a significant reduction (%) in EGFR at 12 months post-transplant (mean difference = 22.6%; P= 0.031). Haplotype analysis showed a significant association between T-T-T haplotypes and an increased incidence of nephrotoxicity at 6 months post-transplantation (haplotype-frequency = 52.9% in nephrotoxic patients vs 29.4% in controls; P= 0.029). Furthermore, G2677-&gt;T and C3435-&gt;T polymorphisms and T-T-T haplotypes were significantly correlated with higher tacrolimus dose-adjusted pre-dose concentrations at various time points examined long after drug initiation. CONCLUSIONS: These findings suggest that ABCB1 polymorphisms in the native intestine significantly influence tacrolimus dosage-requirement in the stable phase after transplantation. In addition, ABCB1 polymorphisms in paediatric liver transplant recipients may predispose them to nephrotoxicity over the first year post-transplantation. Genotyping future transplant recipients for ABCB1 polymorphisms, therefore, could have the potential to individualize better tacrolimus immunosuppressive therapy and enhance drug safety.", "sentences": [], "annotations": [{"id": "31", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 225, "length": 5}]}, {"id": "32", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephrotoxicity", "locations": [{"offset": 251, "length": 14}]}, {"id": "33", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 270, "length": 10}]}, {"id": "34", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 315, "length": 8}]}, {"id": "35", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 425, "length": 10}]}, {"id": "36", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 455, "length": 5}]}, {"id": "37", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 528, "length": 10}]}, {"id": "38", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "renal toxicity", "locations": [{"offset": 624, "length": 14}]}, {"id": "39", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 766, "length": 5}]}, {"id": "40", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 803, "length": 8}]}, {"id": "41", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "renal dysfunction", "locations": [{"offset": 817, "length": 17}]}, {"id": "42", "infons": {"identifier": "MESH:D001260", "type": "Disease"}, "text": "T-T-T", "locations": [{"offset": 1250, "length": 5}]}, {"id": "43", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephrotoxicity", "locations": [{"offset": 1297, "length": 14}]}, {"id": "44", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephrotoxic", "locations": [{"offset": 1377, "length": 11}]}, {"id": "45", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1389, "length": 8}]}, {"id": "46", "infons": {"identifier": "MESH:D001260", "type": "Disease"}, "text": "T-T-T", "locations": [{"offset": 1490, "length": 5}]}, {"id": "47", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1549, "length": 10}]}, {"id": "48", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1699, "length": 5}]}, {"id": "49", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 1767, "length": 10}]}, {"id": "50", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1853, "length": 5}]}, {"id": "51", "infons": {"identifier": "MESH:D007674", "type": "Disease"}, "text": "nephrotoxicity", "locations": [{"offset": 1938, "length": 14}]}, {"id": "52", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 2039, "length": 5}]}, {"id": "53", "infons": {"identifier": "MESH:D016559", "type": "Chemical"}, "text": "tacrolimus", "locations": [{"offset": 2120, "length": 10}]}], "relations": []}], "relations": [], "pmid": 19740399, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D001260", "species@9606", "disease@MESH:D007674", "chemical@MESH:D016559", "gene@5243"], "journal": "Br J Clin Pharmacol", "year": 2009, "authors": ["Hawwa AF", "McKiernan PJ", "Shields M", "Millership JS", "Collier PS", "McElnay JC"]}
